XML 20 R3.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expenses:    
Research and development $ 14,751 $ 10,131
General and administrative 9,040 5,576
Total operating expenses 23,791 15,707
Operating loss (23,791) (15,707)
Other income, net 885 1,218
Net loss (22,906) (14,489)
Other comprehensive loss:    
Net unrealized (loss) gain on marketable securities (54) 3
Foreign currency translation adjustment (54) 42
Comprehensive loss $ (23,014) $ (14,444)
Net loss per share — basic and diluted (in USD per share) $ (0.31) $ (0.23)
Weighted-average common shares used to compute net loss per share - basic and diluted (in shares) 73,797 63,125